帕金森病与骨质疏松性椎体压缩骨折风险:一项全国性人群研究
该研究利用韩国国民健康保险数据库2004至2013年数据,纳入60岁以上帕金森病患者3370例及按年龄性别匹配的非帕金森病对照16850例,发现帕金森病与骨质疏松、骨质疏松性椎体压缩骨折及该类骨折手术风险升高相关,且帕金森病合并骨折患者接受手术治疗似乎与更好预后相关。
要点
- 帕金森病患者骨质疏松性椎体压缩骨折发生率为12.5%,对照组为7.4%。
- 帕金森病与骨质疏松(HR 1.32)、椎体压缩骨折(HR 1.66)及骨折手术(HR 2.69)风险升高相关。
- 帕金森病患者接受椎体骨折手术后生存率呈现优于保守治疗的趋势。
核心结论
- 帕金森病患者骨质疏松和骨质疏松性椎体压缩骨折风险显著增加。
- 帕金森病患者椎体压缩骨折手术治疗与优于保守治疗的预后相关。
研究设计与样本
- 研究为基于韩国国民健康保险数据库的全国性人群研究,收集2004至2013年60岁以上帕金森病患者数据(n=3370)。
- 对照组为非帕金森病患者(每例帕金森病患者匹配5例,n=16850),按年龄和性别每年新诊断匹配。
- 采用Cox比例风险回归分析骨质疏松、椎体压缩骨折、骨折手术与帕金森病的关系,并评估家庭收入和居住区域。
主要发现
- 帕金森病组骨质疏松性椎体压缩骨折发生率为12.5%,对照组为7.4%。
- 帕金森病与骨质疏松风险升高相关(HR 1.32;95%CI 1.21-1.43;p<0.001)。
- 帕金森病与骨质疏松性椎体压缩骨折风险升高相关(HR 1.66;95%CI 1.47-1.87;p<0.001)。
- 帕金森病与骨质疏松性椎体压缩骨折手术风险升高相关(HR 2.69;95%CI 1.78-4.08;p<0.001)。
- 调整潜在混杂因素后,帕金森病组死亡率约为非帕金森病组的1.7倍;帕金森病合并椎体骨折组死亡率高于非帕金森病组但未达统计学显著(p=0.09)。
关键数值与推荐
- 家庭收入与骨质疏松发生、椎体压缩骨折发生率或椎体骨折手术无显著相关。
- 居住区域与骨质疏松、椎体压缩骨折及椎体骨折手术有统计学关联。
- 帕金森病合并椎体骨折手术组生存率呈现优于保守治疗组的趋势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Patients with Parkinson's disease (PD) were at higher risk of osteoporotic vertebral compression fractures (OVCF) compared to controls and had elevated mortality rates. Compared to conservative treatment, surgical treatment for OVCF in PD patients seemed to be associated with better outcomes. INTRODUCTION: The purpose of this study was to evaluate the risk of OVCF in patients with PD. METHODS: Data from patients over the age of 60 years who were diagnosed with PD were collected between 2004 and 2013 from the Korean National Health Insurance Database (n = 3370). The comparison group (non-PD) consisted of randomly selected patients (five per patient with PD; n = 16,850) matched to the PD group, who were newly diagnosed annually according to age and sex. Cox proportional hazard regressions were used to examine the relationships between osteoporosis, OVCF, surgery for OVCF, and PD. Household income and residential area of patients were also assessed. Overall survival rates were calculated after adjusting for confounding factors, such as hypertension, diabetes mellitus, and chronic kidney disease. RESULTS: OVCF was developed in 12.5% of patients in the PD group and in 7.4% of patients in the control group. PD was associated with increased risk of osteoporosis (hazard ratio [HR], 1.32; 95% confidence interval [CI], 1.21-1.43; p < 0.001), OVCF (HR 1.66; 95% CI, 1.47-1.87; p < 0.001), and surgery for OVCF (HR 2.69; 95% CI, 1.78-4.08; p < 0.001). Household income was not significantly related with development of osteoporosis, incidence of OVCF, or surgery for OVCF. Residential area was statistically associated with osteoporosis, OVCF, and surgery for OVCF. The mortality rate of the PD group was about 1.7 times higher than that of the non-PD group after adjusting for potential confounders, and the mortality rate of the PD with OVCF group was higher than that of the non-PD group, but not significantly (p = 0.09). The survival rate of the PD group with surgery for OVCF showed a trend toward a more positive prognosis compared with that of the PD group with conservative treatment. CONCLUSIONS: Patients with PD had significantly increased risk of osteoporosis and OVCF. Surgical treatment for OVCF in PD patients was associated with a better prognosis than conservative treatment.
引用
- Lee CK, Choi SK, Shin DA, et al. Parkinson's disease and the risk of osteoporotic vertebral compression fracture: a nationwide population-based study. Osteoporos Int. 2018. PMID: 29460103. doi:10.1007/s00198-018-4409-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。